Reflections on the immunology of tuberculosis: Will we ever unravel the skein?

BMC Infectious Diseases

Volumn 14, Issue , 2014, Pages

  de Martino, Maurizio ^a   Galli, Luisa ^a   Chiappin, Elena ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MONOCLONAL ANTIBODY; MYCOBACTERIUM ANTIGEN; TUMOR NECROSIS FACTOR; ANTIBODY;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE; BACTERIAL LOAD; BACTERIAL TRANSMISSION; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; GRANULOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INNATE IMMUNITY; LATENT TUBERCULOSIS; LUNG ALVEOLUS MACROPHAGE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; TUBERCULOSIS; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; REVIEW;

ADAPTIVE IMMUNITY; ANTIBODIES; B-LYMPHOCYTES; GRANULOMA; HUMANS; IMMUNITY, INNATE; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 84906910118     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-S1-S1     Document Type: Article

References (52)

1. Ernst JD: The immunological life cycle of tuberculosis. Nature Rev 2012, 12:581-591.
2. Zumla A, Raviglione M, Hafner R, von Reyn F: Tuberculosis. N Engl J Med 2013, 368:745-755.
3. Cooper AM, Torrado E: Protection versus pathology in tuberculosis: recent insights. Curr Opin Immunol 2012, 24:431-437.
4. Zuniga J, Torres-Garcia D, Santos Mendoza T, Rodriguez-Reyna TS, Granados J, Yunis EJ: Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Develop Immunol 2012, ID 193923 doi: 10.1155/2012/193923.
5. Roy RB, Whittaker E, Kampmann B: Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis 2012, 25:250-257.
6. Cooper AM, Adams LB, Dalton DK, Appleberg R, Ehlers S: IFN-γ and NO in mycobacterial diseases:new jobs for old hands. Trends Microbiol 2002, 10:221-222.
7. Kaufmann SHE: How can immunology contribute to the control of tuberculosis? Nature Rev Immunol 2001, 1:20-30.
8. Kim JS, Kim WS, Choi HG, Jang B, Lee K, Park JH, Kim HJ, Cho SN, Shin SJ: Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells. J Leukoc Biol 2013, [Epub ahead of print.
9. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A: TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005, 202:1715-1724.
10. Banaiee N, Kincaid EZ, Buchwald U, Jacobs WR Jr, Ernst JD: Potent inhibition of cytokines in the balance of protection and pathology during mycobacterial infections. Adv Exp Med Biol 2013, 783:121-140.
11. Thada S, Valluri VL, Gaddam SL: Influence of toll-like receptor gene polymorphisms to tuberculosis susceptibility in humans. Scand J Immunol 2013, 78:221-229.
12. Torrado E, Cooper AM: Macrophage responses to IFN-γ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 2006, 176:3019-3027.
13. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM: Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T cell immunity. Infect Immun 2002, 70:4501-4509.
14. Huynh KK, Joshi SA, Brown EJ: A delicate dance: host response to mycobacteria. Curr Opin Immunol 2011, 23:464-472.
15. Blomgran R, Desvignes L, Briken V, Ernst JD: Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe 2012, 11:81-90.
16. Abdallah AM, Bestebroer J, Savage ND, de Punder K, van Zon M, Wilson L, Korbee CJ, van der Sar AM, Ottenhoff TH, van der Wel NN, Bitter W, Peters PJ: Mycobacterial secretion systems ESX-1 and ESX-5 play distinct roles in host cell death and inflammasome activation. J Immunol 2011, 187:4744-4753.
17. Pym A, Brodin P, Brosch R, Huerre M, Cole S: Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002, 46:709-717.
18. Scott-Browne JP, Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, Bevan MJ, Urdahl KB: Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 2007, 204:2159-2169.
19. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, Fountain JJ, Martino CA, Roberts AD, Cooper AM, Winslow GM, Woodland DL: ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci USA 2008, 105:10961-10966.
20. Black GF, Thiel BA, Ota MO, Parida SK, Adegbola R, Boom WH, Dockrell HM, Franken KL, Friggen AH, Hill PC, Klein MR, Lalor MK, Mayanja H, Schoolnik G, Stanley K, Weldingh K, Kaufmann SH, Walzl G, Ottenhoff TH: Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol 2009, 16:1203-1212.
21. Torrado E, Cooper AM: IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev 2010, 21:455-462.
22. Meraviglia S, El Daker S, Dieli F, Martini F, Martino A: δd T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection. Clin Dev Immunol 2011, ID 587315. doi: 10.1155/2011/587315.
23. World Health Organization: Tuberculosis., Fact sheet no104, February 2013.
24. Rogerson BJ, Jung YJ, LaCourse R, Ryan L, Enright N, North RJ: Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. Immunology 2006, 118:195-201.
25. Geldmacher C, Zumla A, Hoelscher M: Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS 2012, 7:268-275.
26. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, Cush JJ, Mejias A, Ramilo O, Kon OM, Pascual V, Banchereau J, Chaussabel D, O'Garra A: An interferon inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
27. Poulsen A: Some clinical features of tuberculosis. Acta Tuberc. Scand 1950, 24:311-346, I. Incubation period.
28. Harari A, Dutoit V, Cellerai C, Bart P-A, Du Pasquier RA, Pantaleo G: Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006, 211:236-254.
29. Millington KA, Gooding S, Hinks TS, Reynolds DJ, Lalvani A: Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosis. J Infect Dis 2010, 202:1685-1689.
30. Rodrigo T, Caylà JA, García de Olalla P, Galdós-Tangüis H, Jansà JM, Miranda P, Brugal T: Characteristics of tuberculosis patients who generate secondary cases. Int J Tuberc Lung Dis 1997, 1:352-357.
31. Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, Mathema B, Ramaswamy SV, Walther G, Steyn LM, Barry CE 3rd, Bekker LG: Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity:. Infect Immun 2003, 71:7099-7108.
32. Kwan CK, Ernst JD: HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011, 24:351-376.
33. Kapur V, Whittam TS, Musser JM: Is Mycobacterium tuberculosis 15, 000 years old? J Infect Dis 1994, 170:1348-1349.
34. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, Kremer K, Ernst JD, Gagneux S: Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nature Genet 2010, 42:498-503.
35. Blouin Y, Hauck Y, Soler C, Fabre M, Vong R, Dehan C, Cazajous G, Massoure PL, Kraemer P, Jenkins A, Garnotel E, Pourcel C, Vergnaud G: Significance of the identification in the Horn of Africa of an exceptionally deep branching Mycobacterium tuberculosis clade. PLoS One 2012, 7:e52841, doi: 10.1371/journal.pone.0052841.
36. Morton R: Phthisiologia: or, a treatise of consumptions: wherein the difference, nature, causes, signs, and cure of all sorts of consumptions are explained. W and J Innys, London; 1720.
37. Shaler CR, Horvath CN, Jeyanathan M, Xing Z: Within the enemy's camp: contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis. Front Immunol 2013, 4, doi: 10.3389/fimmu 2013.00030.
38. Guirado E, Schlesinger LS: Modeling the Mycobacterium tuberculosis granuloma-the critical battlefield in host immunity and disease. Front Immunol 2013, 4, doi:10.3389/fimmu.2013.00098.
39. Ramakrishnan L: Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 2012, 12:352-366.
40. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L: Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 2010, 327:466-469.
41. Ramakrishnan L: Looking within the zebrafish to understand the tuberculous granuloma. Adv Exp Med Biol 2013, 783:251-266.
42. Davis JM, Ramakrishnan L: The role of granuloma in expansion and dissemination of early tuberculous infection. Cell 2009, 136:37-49.
43. Bourigault ML, Vacher R, Rose S, Olleros ML, Janssens JP, Quesniaux VF, Garcia I: Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology. Am J Clin Exp Immunol 2013, 2:124-134.
44. Phuah JY, Mattila JT, Lin PL, Flynn JL: Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis. Am J Pathol 2012, 181:508-514.
45. Achkar JM, Casadevall A: Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe 2013, 13:250-262.
46. Kozakiewicz L, Phuah J, Flynn J, Chan J: The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. Adv Exp Med Biol 2013, 783:225-250.
47. Maglione PJ, Chan J: How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol 2009, 39:676-686.
48. Shen CY, Hsieh SC, Yu CL, Wang JY, Lee LN, Yu CJ: Autoantibody prevalence in active tuberculosis: reactive or pathognomonic? BMJ Open 2013, 3, doi:pii: e002665. 10.1136/bmjopen-2013-002665.
49. Thada S, Valluri VL, Gaddam SL: Influence of toll-like receptor gene polymorphysms to tuberculosis suscepribility in humans. Scand J Immunol 2013, 78:221-229.
50. Azad AK, Sadee W, Schlesinger LS: Innate gene polymorphisms in tuberculosis. Infect Immun 2012, 80:3343-3359.
51. Songane M, Kleinnijenhuis J, Netea MG, van Crevel R: The role of autophagy in host defence against Mycobacterium tuberculosis infection. Tuberculosis 2012, 92:388-396.
52. Abebe F: Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology. Clin Exp Immunol 2012, 169:213-219.